Pablo Angeles Tacchino
LightNews LightNews
banner
pabloangelest.bsky.social
Pablo Angeles Tacchino
@pabloangelest.bsky.social
210 followers 320 following 21 posts
Médico Nefrólogo
Posts Replies Media Videos
pabloangelest.bsky.social
so the HiLo study was unremarkable in the treatmet of Hyperphosphahtemia, will the Phosphate trial tell us something different?
July 11, 2025 at 12:52 PM
pabloangelest.bsky.social
June 7, 2025 at 3:35 PM
pabloangelest.bsky.social
#era25 following through social media expectorante the resultado of CONFIDENCE trial.
June 4, 2025 at 9:37 PM
pabloangelest.bsky.social
In Heart Failure, Finerenone 20-40mg vs placebo, ↓ cardiorenal risks, effect appears to be independient of the renal risk, ↓ albuminuria more Benefit in renal outcome

PostHoc of FINEARTS-HF
JACC 2025. doi.org/10.1016/j.jc...
April 7, 2025 at 2:07 PM
pabloangelest.bsky.social
Different guidelines hypertension targets comparisson. HYPERTENSION 2025. #Hypertension
March 17, 2025 at 1:59 PM
pabloangelest.bsky.social
Cool picture . cats claw is quite popular in Peru. #Nephmadness 2025
March 5, 2025 at 1:13 PM
pabloangelest.bsky.social
Interesante
February 28, 2025 at 4:00 AM
pabloangelest.bsky.social
February 24, 2025 at 1:11 AM
pabloangelest.bsky.social
accurate!!
January 31, 2025 at 2:50 AM
pabloangelest.bsky.social
Siempre Interesante anticoagulacion en HD.RevisionCKJ 2024 doi.org/10.1093/ckj/...
January 29, 2025 at 9:11 PM
pabloangelest.bsky.social
NDT 2025
January 27, 2025 at 11:36 PM
pabloangelest.bsky.social
Con el presidente saliente de la sociedad peruana de nefrología con la gente Pocus perucho @lluncornefro.bsky.social @irwingbenites
January 25, 2025 at 10:02 PM
pabloangelest.bsky.social
CkJ 2025 spirnolactone in intradialityc Hypertension academic.oup.com/ckj/advance-ar
January 18, 2025 at 4:30 AM